PROFIL

BMS

Laboratoire pharmaceutique Bristol-Myers Squibb France.

Aucun article n’a été trouvé

Fil Twitter

Bristol-Myers Squibb
Thanks to our researchers for joining the #IION discussion in Philadelphia. Visit t.co/VkCZ0NAmp9 to learn… t.co/cuCnEXcfGS
Bristol-Myers Squibb
DYK: #IION includes 350+ investigators collaborating on 190+ #IO research projects. Learn more about our work:… t.co/SdZqtloNIr
Bristol-Myers Squibb
#DYK: The II-ON is one of the first networks to bring academia and industry together to accelerate translational… t.co/ewuFYCw1gE
Bristol-Myers Squibb
#MEDIA: European Commission expands indication of our advanced #melanoma treatment for pediatric patients 12 and ol… t.co/BzrfUAIW2u
Bristol-Myers Squibb
#DYK that approximately 4% of metastatic #ColorectalCancers have #dMMR or MSI-H tumors? Learn more here:… t.co/YZPsUu37m5
Bristol-Myers Squibb
#MEDIA: Announcing new #Immunotherapy combination data in metastatic #ColorectalCancer at #GI18:… t.co/EEO7SgjFKm
Bristol-Myers Squibb
Thanks @FortuneMagazine for naming us a #MostAdmired company this year. Learn how we’re driving #innovation for… t.co/pHIUommbFD
Bristol-Myers Squibb
This week, we’ll be in Philadelphia for the 5th Annual II-ON Symposium! Learn more about #IION and our commitment t… t.co/YmQvEzYtYK
Bristol-Myers Squibb
Poll complete. The correct answer to our poll was Hepatocellular carcinoma, or #HCC. There are approximately 700,00… t.co/2pAG8N9riI

Commentaires sur vih.org

Commentaires (0)